Kolexia
Menu Yves
Radio-diagnostic
Hôpital Saint-Antoine
Paris, France
111 Activités
111 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du foie Carcinome hépatocellulaire Carcinomes Tumeurs colorectales Instabilité des microsatellites Angiocholite Maladies du foie Fibrose Adénocarcinome

Industries

Bayer
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
A chapter closes, legacy endures: farewell as Editor in Chief.
European radiology   05 décembre 2023
NIPICOL: Interest of iRECIST Radiological Assessment for Disease Control Rate (DCR) for Evaluation of Patients With Metastatic Colorectal Cancer dMMR and/or MSI Treated With Nivolumab and Ipilimumab. A GERCOR Open-label Phase II Study NIPICOL C17-01
Essai Clinique (BMS)   26 septembre 2023
From Dose Reduction to Contrast Maximization: Can Deep Learning Amplify the Impact of Contrast Media on Brain Magnetic Resonance Image Quality? A Reader Study.
Investigative radiology   20 avril 2022
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   15 avril 2022
Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study.
Investigative radiology   14 avril 2022
Evaluating the Impact of Peer Review on the Completeness of Reporting in Imaging Diagnostic Test Accuracy Research.
Journal of magnetic resonance imaging : JMRI   15 février 2022
One-year duration of nivolumab plus ipilimumab in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC): Long-term follow-up of the GERCOR NIPICOL phase II study.
2022 ASCO Gastrointestinal Cancers Symposium   19 janvier 2022
Letter to the Editor from Colle .
Journal for immunotherapy of cancer   13 octobre 2021
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study.
Journal for immunotherapy of cancer   16 septembre 2021